Fabrice Joulia

Dr. Fabrice Joulia

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2009 in Acta Physiologica
Verified
Journal Article
Closed access
PDF file
FJFabrice Joulia
Fabrice Joulia
FLF. Lemaitre
F. Lemaitre
PFP. Fontanari
P. Fontanari
MMM. L. Mille
M. L. Mille
PBP. Barthelemy
P. Barthelemy

25 March 2019 in Physiological Reports
Verified
Journal Article
Open access
PDF file
MMMarion Marlinge
Marion Marlinge
MCMathieu Coulange
Mathieu Coulange
RFRichard C. Fitzpatrick
Richard C. Fitzpatrick
RDRomain Delacroix
Romain Delacroix
AGAlexie Gabarre
Alexie Gabarre
FJFabrice Joulia
Fabrice Joulia
This study investigated the sources of physiological stress in diving by comparing SCUBA dives (stressors: hydrostatic pressure, cold, and hyperoxia), apneic dives (hydrostatic pressure, cold, physical activity, hypoxia), and dry static apnea (hypoxia only). We hypothesized that despite the hypoxia induces by a long static apnea, it would be less stressful than SCUBA dive or apneic dives since the latter combined high pressure, physical activity, and cold exposure. Blood samples were collected from 12SCUBA and 12 apnea divers before and after dives. On a different occasion, samples were collected from the apneic group before and after a maximal static dry apnea. We measured changes in levels of the stress hormones cortisol and copeptin in each situation. To identify localized effects of the stress, we measured levels of the cardiac injury markers troponin (cTnI) and brain natriuretic peptide (BNP), the muscular stress markers myoglobin and lactate), and the hypoxemia marker ischemia‐modified albumin (IMA). Copeptin, cortisol, and IMA levels increased for the apneic dive and the static dry apnea, whereas they decreased for the SCUBA dive. Troponin, BNP, and myoglobin levels increased for the apneic dive, but were unchanged for the SCUBA dive and the static dry apnea. We conclude that hypoxia induced by apnea is the dominant trigger for the release of stress hormones and cardiac injury markers, whereas cold or and hyperbaric exposures play a minor role. These results indicate that subjects should be screened carefully for pre‐existing cardiac diseases before undertaking significant apneic maneuvers.

7 February 2008
Verified
Journal Article
Closed access
FLF Lemaître
F Lemaître
DPD Polin
D Polin
FJFabrice Joulia
Fabrice Joulia
ABA Boutry
A Boutry
DPD Le Pessot
D Le Pessot
CTC Tourny-Chollet
C Tourny-Chollet

5 October 2021 in Frontiers in Physiology
Verified
Journal Article
Open access
MMMarion Marlinge
Marion Marlinge
MCMohamed Chefrour
Mohamed Chefrour
FBFrançois Billaut
François Billaut
MZMarion Zavarro
Marion Zavarro
JRJean-Claude Rostain
Jean-Claude Rostain
FJFabrice Joulia
Fabrice Joulia
The physiopathology consequences of hypoxia during breath-hold diving are a matter of debate. Adenosine (AD), an ATP derivative, is suspected to be implicated in the adaptive cardiovascular response to apnea, because of its vasodilating and bradycardic properties, two clinical manifestations observed during voluntary apnea. The aim of this study was to evaluate the adenosine response to apnea-induced hypoxia in trained spearfishermen (SFM) who are used to perform repetitive dives for 4–5 h. Twelve SFM (11 men and 1 woman, mean age 41 ± 3 years, apnea experience: 18 ± 9 years) and 10 control (CTL) subjects (age 44 ± 7 years) were enrolled in the study. Subjects were asked to main a dry static apnea and stopped it when they began the struggle phase (average duration: SFM 120 ± 78 s, CTL 78 ± 12 s). Capillary blood samples were collected at baseline and immediately after the apnea and analyzed for standard parameters and adenosine blood concentration ([AD]b). Heart rate (HR), systolic (SBP), and diastolic (DBP) blood pressures were also recorded continuously during the apnea. During the apnea, an increase in SBP and DBP and a decrease in HR were observed in both SFM and CTL. At baseline, [AD]b was higher in SFM compared with CTL (1.05 ± 0.2 vs. 0.73 ± 0.11 μM, p < 0.01). [AD]b increased significantly at the end of the apnea in both groups, but the increase was significantly greater in SFM than in controls (+90.4 vs. +12%, p < 0.01). Importantly, in SFM, we also observed significant correlations between [AD]b and HR (R = −0.8, p = 0.02), SpO2 (R = −0.69, p = 0.01), SBP (R = −0.89, p = 0.02), and DBP (R = −0.68, p = 0.03). Such associations were absent in CTL. The adenosine release during apnea was associated with blood O2 saturation and cardiovascular parameters in trained divers but not in controls. These data therefore suggest that adenosine may play a major role in the adaptive cardiovascular response to apnea and could reflect the level of training.

28 June 2026 in Antioxidants
Verified
Journal Article
Open access
PDF file
PMPierrick Martinez
Pierrick Martinez
EMEnrique A Martinez
Enrique A Martinez
LGLionel Gillot
Lionel Gillot
WMWilliam Makis
William Makis
CPCasey Peavler
Casey Peavler
William B. GrantWilliam B. Grant
William B. Grant
Supplements are widely perceived as safe and beneficial; yet in oncology, this assumption is questionable. Clinical trials over the past few decades have often produced disappointing results, raising a critical question: are these agents used correctly, or could they inadvertently cause harm? This review examines supplements frequently used in cancer care—such as oral vitamin C, berberine, N-acetylcysteine, vitamin D, vitamin E, melatonin, polyphenols, alpha-lipoic acid, selenium, and coenzyme Q10—which can act as tumor suppressors or promoters depending on dose, route, and disease stage. We examine their dual antioxidant and pro-oxidant properties, revealing that therapeutic outcomes are shaped not only by the molecule itself, but also by bioavailability, dosing thresholds, and the tumor redox environment. Building on these insights, we propose that four factors may be considered to guide clinical use: ensure that anticancer effects are not overshadowed by antioxidant activity, achieve sufficient bioavailability, confirm pro-oxidant concentrations where possible, and prioritize supplements that target the respiration-supported non-OxPhos pathways. By framing supplements as context-dependent redox modulators rather than universally beneficial agents, this review provides a mechanistically grounded framework for informing future research and safer, more effective integrative oncology strategies.

1 September 2023 in Frontiers in Physiology
Verified
Journal Article
Open access
FJFabrice Joulia
Fabrice Joulia
DDDaniel Daly
Daniel Daly
AGAlexandre Guimard
Alexandre Guimard
Editorial: Training, performance and rehabilitation in water-based sports